SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-030437
Filing Date
2008-05-16
Accepted
2008-05-16 16:16:50
Documents
1
Period of Report
2008-05-06

Document Format Files

Seq Description Document Type Size
1 v114036_ex.html 3  
1 v114036_ex.xml 3 9669
  Complete submission text file 0001144204-08-030437.txt   11386
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 212-531-5970
Oliviero James F III (Reporting) CIK: 0001434718 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30929 | Film No.: 08842556